Dr. Sridharan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2015 - 2018- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2012 - 2015
Saint Louis University School of MedicineClass of 2012
Certifications & Licensure
MN State Medical License 2013 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Evaluating the potential for iodinated radiocontrast agents to interfere with ADAMTS13 activity testing via fluorescence resonance energy transfer methodology.Jeremy W Jacobs, Melissa S Stuart, Julie I Tange, Rachel R Leger, Aneel A Ashrani
American Journal of Clinical Pathology. 2024-12-05 - Relapse Free Survival Progressive Shortens in a Subset of Black patients with Immune TTP Treated in the Rituximab Era.Ayotola A Fatola, Michael D Evans, Jenna Brown, Elizabeth Davis, Andrew David Johnson
Blood Advances. 2024-12-03 - The clinical impact of acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia: an underrecognized source of major bleeding events.Karan L Chohan, Rajiv K Pruthi, Saurabh Zanwar, Jonas Paludo, Ronald Go
Leukemia. 2024-11-01
Abstracts/Posters
- Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian PopulationsMeera Sridharan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic PurpuraMeera Sridharan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Collaborative Study Discovers New Disease Behind Patient’s Blood ClotsApril 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
